Detalhe da pesquisa
1.
Assessing the need for routine safety testing for patients being treated with dupilumab for moderate-to-severe atopic dermatitis.
Br J Dermatol
; 182(6): e186-e209, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32476149
2.
Laboratory safety of dupilumab in moderate-to-severe atopic dermatitis: results from three phase III trials (LIBERTY AD SOLO 1, LIBERTY AD SOLO 2, LIBERTY AD CHRONOS).
Br J Dermatol
; 182(5): 1120-1135, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31407311
3.
Dupilumab provides important clinical benefits to patients with atopic dermatitis who do not achieve clear or almost clear skin according to the Investigator's Global Assessment: a pooled analysis of data from two phase III trials.
Br J Dermatol
; 181(1): 80-87, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30791102
4.
Conjunctivitis in dupilumab clinical trials.
Br J Dermatol
; 181(3): 459-473, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30851191
5.
One-year safety and efficacy of ustekinumab and results of dose adjustment after switching from inadequate methotrexate treatment: the TRANSIT randomized trial in moderate-to-severe plaque psoriasis.
Br J Dermatol
; 170(2): 435-44, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24116868
6.
Transition to ustekinumab in patients with moderate-to-severe psoriasis and inadequate response to methotrexate: a randomized clinical trial (TRANSIT).
Br J Dermatol
; 170(2): 425-34, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24116959
7.
The safety of calcitriol 3 microg/g ointment. Evaluation of cutaneous contact sensitization, cumulative irritancy, photoallergic contact sensitization and phototoxicity.
Eur J Dermatol
; 11(3): 219-24, 2001.
Artigo
em Inglês
| MEDLINE | ID: mdl-11358728
8.
Calcium homeostasis remains unaffected after 12 weeks' therapy with calcitriol 3 microg/g ointment; no correlation with extent of psoriasis.
J Dermatolog Treat
; 14(1): 14-21, 2003 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-12745850
9.
Polarized light photography and videomicroscopy greatly enhance the capability of estimating the therapeuic response to a topical retinoid (adapalene) in acne vulgaris.
Cutis
; 68(4 Suppl): 25-33, 2001 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-11845945
10.
New photographic techniques for clinical evaluation of acne.
J Eur Acad Dermatol Venereol
; 15 Suppl 3: 13-8, 2001.
Artigo
em Inglês
| MEDLINE | ID: mdl-11843228
11.
Topical calcitriol--studies on local tolerance and systemic safety.
Br J Dermatol
; 144 Suppl 58: 3-10, 2001 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-11501511
12.
Adapalene 0.1% gel and adapalene 0.1% cream stimulate retinoic acid receptor mediated gene transcription without significant irritative effects in the skin of healthy human volunteers.
Br J Dermatol
; 139 Suppl 52: 12-6, 1998 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-9990415